Belgium vs Bolivia, Plurinational State of: Treatment success rate for patients treated for MDR-TB
Belgium
47.0%
in 2022
Bolivia, Plurinational State of
42.0%
in 2022
Belgium rank
146th
Bolivia, Plurinational State of rank
149th
Treatment success rate for patients treated for MDR-TB over time
- Belgium
- Bolivia, Plurinational State of
How they compare
Belgium currently reports 47.0% against 42.0% in Bolivia, Plurinational State of, a difference of 5.0%.
That makes Belgium's figure about 1.1 times Bolivia, Plurinational State of's.
The two have swapped places 9 times across 16 shared years of data; in 2007 it was Bolivia, Plurinational State of ahead.
Belgium ranks 146th and Bolivia, Plurinational State of ranks 149th of 163 countries.
Across the 3 decades both report, Belgium averaged higher in 1 and Bolivia, Plurinational State of in 2.
Head to head by decade
| Decade | Belgium | Bolivia, Plurinational State of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.7% | 66.7% | 19.0% | Bolivia, Plurinational State of |
| 2010s | 75.2% | 62.2% | 13.0% | Belgium |
| 2020s | 50.0% | 52.0% | 2.0% | Bolivia, Plurinational State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Belgium or Bolivia, Plurinational State of?
- Belgium, at 47.0% against 42.0% in Bolivia, Plurinational State of as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Belgium and Bolivia, Plurinational State of?
- 5.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Bolivia, Plurinational State of?
- 16 years are reported by both, from 2007 to 2022.
- How do Belgium and Bolivia, Plurinational State of rank globally for treatment success rate for patients treated for mdr-tb?
- Belgium ranks 146th and Bolivia, Plurinational State of ranks 149th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.